FDA
-
-
-
-
-
-
-
Emmaus Life Sciences (EMMA) receives FDA approval for Endari
-
-
-
-
-
-
-
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
-
-
-
-
-
-
-
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
-
-
-
-
-
-
-
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Soci
-
-
-
-
-
-
-
Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights
-
-
-
-
-
-
-
Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review
-
-
-
-
-
-
-
FDA Approves Updated Label for Endari®
-
322,245 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

